Deal

BAXTER INTERNATIONAL INC acquires Hill-Rom Holdings, Inc. (Hillrom)

December 2021 full acquisition ready

Snapshot

BAXTER INTERNATIONAL INC acquired Hill-Rom Holdings, Inc. (Hillrom) for $156.00 per share, approximately $10.5 billion equity value (approximately $12.8 billion enterprise value including assumed debt) in December 2021. The transaction was structured as all cash. Hill-Rom Holdings, Inc. (Hillrom) is a Chicago, Illinois, USA (global operations)-based Connected care / medical technology business.

Acquirer
BAXTER INTERNATIONAL INC
Target
Hill-Rom Holdings, Inc. (Hillrom)
Value
$156.00 per share, approximately $10.5 billion equity value (approximately $12.8 billion enterprise value including assumed debt)
Date
December 2021
Type
full acquisition
Status
ready
01 Scorecard

The deal at a glance

Private-market deal
BAXTER INTERNATIONAL INC acquires Hill-Rom Holdings, Inc. (Hillrom)
Deal value
$156.00 per share, approximately $10.5 billion equity value (approximately $12.8 billion enterprise value including assumed debt)
Sector
Connected care / medical technology
Date
December 2021
VectorShift
Made on VectorShift

About this deal

BAXTER INTERNATIONAL INC acquired Hill-Rom Holdings, Inc. (Hillrom) for $156.00 per share, approximately $10.5 billion equity value (approximately $12.8 billion enterprise value including assumed debt), a transaction completed in December 2021, structured as all cash.

Hill-Rom Holdings, Inc. (Hillrom) operates in Connected care / medical technology, is based in Chicago, Illinois, USA (global operations), had revenue of about Approximately $2.9 billion in net sales (per Baxter's acquisition announcement). Hillrom is a global medical technology leader whose products and services help enable earlier diagnosis and treatment, optimize surgical efficiency, and accelerate patient recovery while shifting care closer to home, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices and advanced surgical equipment.

Brings together two leading medical technology companies to broaden access to care in the hospital, home and alternate site settings, accelerates digitally-enabled connected care solutions across the continuum of care, and builds on Baxter's global footprint to expand Hillrom's penetration of international markets.

Adds a global connected-care and medical-technology platform spanning the hospital, home and alternate-site settings, with expected high-single-digit ROIC by year five. Baxter expected the transaction to generate high-single digit return on invested capital (ROIC) by year five and significant cost synergies. Operated as Baxter's new global Hillrom segment

Baxter and Hillrom share a common vision for transforming healthcare to better serve all patients and providers. Baxter and Hillrom are uniting to meet the challenges of a rapidly evolving global healthcare landscape, while also creating significant value for all the stakeholders we serve.
José (Joe) E. Almeida, Chairman, President and CEO, Baxter
We are confident that Baxter is the ideal partner to enhance our global reach and realize the true potential of our vision as we work together to accelerate medical innovation worldwide.
John P. Groetelaars, President and CEO, Hillrom
Advisors not disclosed

No advisory firms have been disclosed for this transaction.

Sources Press releaseSEC filing Last updated

See how VectorShift works for your firm

Request Demo